AVAH vs TNDM

AVAH's Piotroski F-Score of 5/9 indicates a borderline stable financial health, but the absence of an Altman Z-Score and a dangerously high Debt/Equity ratio of 152.32 signal severe financial distress risk. Despite strong revenue growth (22.2% YoY) and impressive earnings surprises (average +362.87% in last 4 quarters), the company trades at a premium valuation (P/E 18.68, Price/Book 147.02) with no dividend and negative ROE. Insider selling totaling $7.14M in 6 months further undermines confidence, while the stock has underperformed over the past 6 months despite a 3-year gain of 506.1%. The Graham Number of $0.63 suggests deep undervaluation, but the intrinsic value of $2.59 is not supported by current fundamentals, indicating the market prices in aggressive growth expectations.

TNDM exhibits severe fundamental weakness, highlighted by a critical Piotroski F-Score of 1/9, indicating poor financial health and operational deterioration. While analysts maintain a 'buy' rating with a target of $30.62, the company suffers from negative profit margins (-20.17%), a deeply negative ROE (-97.89%), and high leverage (Debt/Equity of 2.90). Despite a strong current ratio providing short-term liquidity, the lack of meaningful revenue growth (2.70%) and bearish insider sentiment suggest the current price is speculative rather than fundamentally supported.